🇺🇸 FDA
Patent

US 8232259

Multiple CpG oligodeoxynucleotide and their use to induce an immune response

granted A61KA61K2039/55561A61P

Quick answer

US patent 8232259 (Multiple CpG oligodeoxynucleotide and their use to induce an immune response) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/55561, A61P, A61P31/04, A61P31/10